OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 6, pp. 707-718
Closed Access | Times Cited: 5
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 6, pp. 707-718
Closed Access | Times Cited: 5
Showing 5 citing articles:
Impact of SGLT2 Inhibitors on Preventing Heart Failure Hospitalizations in Colombian Patients With Uncontrolled Type 2 Diabetes Mellitus
Dillon Trujillo, Leonelo E. Bautista, Claudia Espinosa, et al.
Cureus (2025)
Open Access
Dillon Trujillo, Leonelo E. Bautista, Claudia Espinosa, et al.
Cureus (2025)
Open Access
Impact of Angiotensin Receptor-Neprilysin Inhibitors on Patients With Acute Heart Failure Syndrome
David Aristizabal-Colorado, Santiago Sierra Castillo, William Martínez, et al.
Cureus (2025)
Open Access
David Aristizabal-Colorado, Santiago Sierra Castillo, William Martínez, et al.
Cureus (2025)
Open Access
Semaglutide Versus Empagliflozin in Uncontrolled Type 2 Diabetes: A Cohort Study With 18 Months of Follow-Up (SEMPA18)
David Aristizabal-Colorado, Dillon Trujillo, S. Castillo, et al.
Cureus (2025)
Open Access
David Aristizabal-Colorado, Dillon Trujillo, S. Castillo, et al.
Cureus (2025)
Open Access
Comment on “SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect”
Rose Peronard, Stephan Peronard Mayntz
American Journal of Cardiovascular Drugs (2024)
Closed Access | Times Cited: 1
Rose Peronard, Stephan Peronard Mayntz
American Journal of Cardiovascular Drugs (2024)
Closed Access | Times Cited: 1
Author’s Reply to Peronard and Mayntz: “SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect”
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
Effectiveness of a Novel PLA2R1 Knock‐in Middle Age Rat Model in Repairing Renal Function Damage
Daihe Yang, Zitong Zhang, Lu Zhao, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Closed Access
Daihe Yang, Zitong Zhang, Lu Zhao, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Closed Access
